Connected Smart Drug Delivery Systems Market worth $ 7.19 Billion by 2028

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Connected Smart Drug Delivery Systems Market- by Products (Connected Inhalers, Connected Autoinjectors, Connected Needle-Free Injectors, Connected Pen injectors, Connected Insulin Pumps, Connected Wearable Injectors/Patch Pumps, and Add-On Sensors), Therapeutic Area (Metabolic Disorders, Neurological Disorders, Respiratory Disorders and Others), End-User (Hospitals, Clinics and Homecare), Trends, Industry Competition Analysis, Revenue and Forecast To 2028."

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1291

According to the latest research by InsightAce Analytic, the global connected smart drug delivery systems market was valued at US$ 799.3 Million in 2021. It is expected to reach US$ 7190.8 Million by 2028, with a CAGR of 37.4 % during a forecast period of 2022-2028.

To deliver drugs to specified sites or targets, connected/smart drug delivery systems use a variety of strategies, formulations, technology, and apparatus. Connected smart drug delivery systems contribute to a reduction in the associated side effects and an improvement in the therapeutic impact. Treatment for respiratory illnesses, diabetes, and other cardiovascular conditions might greatly benefit from these gadgets.

Sophisticated devices monitor the time and distribution of doses and provide patients with immediate feedback. COVID-19 Due to the pandemic, there is a significantly greater need for such smart (contactless) devices. As a result, there will be a high demand for these systems in the future, ultimately leading to an increase in the need for connected/smart drug delivery devices. Many healthcare facilities have begun utilizing wireless digital gadgets that are easy to use and accurate. Therefore, incorporating features such as remote tracking, dosage reminders, patient feedback, and patient education tools into devices, developing a variety of smartphone applications and user-friendly devices with affordable connectivity, and developing new products in line with patient needs will increase the market's opportunities for market leadership. The possibility that linked smart drug delivery devices will be useful is increased by cooperation between biopharmaceutical companies and healthcare technology suppliers.

North America is anticipated to be the major contributor to the connected smart drug delivery systems market over the forecast years. Due to its high per capita healthcare spending, rapid adoption of the newest technology and devices, and growing awareness of the negative impacts of non-compliance with drug therapy, the region is anticipated to maintain its leadership position during the projection years. In addition, the Asia Pacific connected smart drug delivery systems market is expected to grow significantly during the forecast period. Products are anticipated to become less expensive over time as more competitors enter the market; this will aid in expanding the market in those areas.

Major market players operating in the Connected Smart Drug Delivery Systems market include West Pharmaceutical Services Inc., Emperra GmbH E-Health Technologies, Amiko Digital Health Limited, Cognita Labs, DIAMESCO CO., Ltd., Eitan Medical (Q Core Medical Ltd., Avocet Health, Sorrel Medical), Enable Injections, Bigfoot Biomedical Inc., BIOCORP, Elcam Drug Delivery Devices (E3D), Novo Nordisk, Merck, Pneuma Respiratory, H&T Press part, Nemera, Ypsomed Holdings, Unolife Corporation, Quio Technologies, SHL Group, Haselmeier Inc., Portal Instruments Inc, Medtronic Plc, Companion Medical, Sorrel Medical, Cohero Health, Inc., Propeller Health, Pendiq Intelligent Diabetes Care, Phillips-Medisize, Becton, Dickinson and Company (BD), Noble International Inc, etectRx, Aterica Inc., Findair Sp. z o. o., Recipharm AB, Aero Pump GmbH, Jiangsu Delfu medical device Co., Ltd, and other prominent players.

Recent collaborations and agreements in the market:
In April 2022, to improve patients' experiences with drug therapy, Pneuma Systems Corporation and West Pharmaceutical Services, Inc. formed a complex commercial relationship. West will develop medicine delivery solutions for pharmaceutical companies and clinical end users using Pneuma's exclusive closed-loop fluid flow control platform.
In March 2022, recently, Novo Nordisk strengthened its collaboration with Brigham and Women's Hospital and the Massachusetts Institute of Technology (MIT) on oral medicine delivery research (BWH). The partnership will now extend through 2026, and its purview has been widened to include the creation and incorporation of bioelectronics, biosensors, and delivery systems with stimuli-responsive capabilities.

Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1291

Market Segments
Global Connected Smart Drug Delivery Systems Market, by Products, 2022-2028 (Value US$ Mn)
Connected Inhalers
Connected Autoinjectors
Connected Needle-Free Injectors
Connected Pen injectors
Connected Insulin Pumps
Connected Wearable Injectors/Patch Pumps
Add-On Sensors

Global Connected Smart Drug Delivery Systems Market, by Therapeutic Area, 2022-2028 (Value US$ Mn)
Metabolic Disorders
Neurological Disorders
Respiratory Disorders
Others

Global Connected Smart Drug Delivery Systems Market, by End-User, 2022-2028 (Value US$ Mn)
Hospitals
Clinics
Homecare

Global Connected Smart Drug Delivery Systems Market, by Region, 2022-2028 (Value US$ Mn)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

North America Connected Smart Drug Delivery Systems Market, by Country, 2022-2028 (Value US$ Mn)
U.S.
Canada

Europe Connected Smart Drug Delivery Systems Market, by Country, 2022-2028 (Value US$ Mn)
Germany
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific Connected Smart Drug Delivery Systems Market, by Country, 2022-2028 (Value US$ Mn)
India
China
Japan
South Korea
Australia & New Zealand

Latin America Connected Smart Drug Delivery Systems Market, by Country, 2022-2028 (Value US$ Mn)
Brazil
Mexico
Rest of Latin America

Middle East & Africa Connected Smart Drug Delivery Systems Market, by Country, 2022-2028 (Value US$ Mn)
GCC Countries
South Africa
Rest of Middle East & Africa

Why should buy this report:
To receive a comprehensive analysis of the prospects for the global connected smart drug delivery systems market
To receive an industry overview and future trends of the connected smart drug delivery systems market
To analyze the connected smart drug delivery systems market drivers and challenges
To get information on the connected smart drug delivery systems market value (US$Mn) forecast to 2028
Significant investments, mergers & acquisitions in the connected smart drug delivery systems market industry

For More Information @ https://www.insightaceanalytic.com/customisation/1291

Corporate Office :
Office No.3050, 3rd Floor Marvel Fuego, Magarpatta Rd, Hadapsar, Pune, Maharashtra 411028

Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com

info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

This release was published on openPR.